Effect of disease management on prescription drug treatment: What is the right quality measure?

Disease Management

Volumn 10, Issue 2, 2007, Pages 91-100

  Mattke, Soeren ^a   Jain, Arvind K ^a   Sloss, Elizabeth M ^a   Hirscher, Randy ^a   Bergamo, Giacomo ^a   O'Leary, June F ^a  

^a RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; INTERVENTION STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; TOTAL QUALITY MANAGEMENT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DISEASE MANAGEMENT; FEMALE; HUMANS; INFANT; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; MIDWESTERN UNITED STATES; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; PROGRAM EVALUATION; QUALITY INDICATORS, HEALTH CARE; SELF ADMINISTRATION;

EID: 34248216180     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2006.635     Document Type: Article

References (23)

1. Gilberg K, Laouri M, Wade S, Isonaka S. Analysis of medication use patterns: apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF. J Manag Care Pharm 2003;9: 232-237.
2. Howard PA, Shireman TI, Dhingra A, Ellerbeck EF, Fincham JE. Patterns of ACE inhibitor use in elderly Medicaid patients with heart failure. Am J Geriatr Cardiol 2002;11:287-294.
3. Spencer FA, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Am Heart J 2005;150:838-844.
4. Axtell SS, Ludwig E, Lope-Candeles P. Intervention to improve adherence to ACC/AHA recommended adjunctive medications for the management of patients with an acute myocardial infarction. Clin Cardiol 2001;24:114-118.
5. Williams CM. Using medications appropriately in older adults. Am Fam Physician 2002;66:1917-1924.
6. Agency for Healthcare Research and Quality (AHRQ). National Quality Measures Clearinghouse. Available at: www.qualitymeasures.ahrq.gov. Accessed October 6, 2006.
7. International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Bibliography of medication compliance and persistence (references 2002-2005). Available at: www.ispor.org/sigs/MCP_accomplishments.asp. Accessed October 6, 2006.
8. Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care 2006; 44:300-303.
9. National Committee for Quality Assurance (NCQA). Health plan employer data and information set (HEDIS). Available at: www.ncqa.org/programs/ hedis/2005/index.htm. Accessed February 15, 2007.
10. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252. Available at: www.guideline.gov/summary/summary.aspx? ss=15&doc_id=4771&nbr=003450. Accessed on October 6, 2006.
11. Institute for Clinical Systems Improvement (ICSI). Management of type 2 diabetes mellitus. Bloomington, MN: Institute for Clinical Systems Improvement (ICSI), 2005. Available at: www.guideline.gov/summary/summary.aspx?ss= 15&doc_id=8413&nbr=00 4710. Accessed on October 6, 2006.
12. Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of chest pain and acute coronary syndrome (ACS). Bloomington, MN: Institute for Clinical Systems Improvement (ICSI), 2005. Available at: www.guideline.gov/summary/summary.aspx? ss=15&doc_id=8362&nbr=004683. Accessed on October 6, 2006.
13. Intracorp. Bronchitis. Philadelphia: Intracorp, 2005. Available at: www.guideline.gov/summary/ summary.aspx?ss=15&doc_id=7060&nbr=004249. Accessed on October 6, 2006.
14. United States Preventive Services Task Force (USPTF). Aspirin for the primary prevention of cardiovascular events: recommendations and rationale. Ann Intern Med 2002;136:157-160. Available at: www.guideline.gov/summary/summary. aspx?ss= 15&doc_id=3079&nbr=2305. Accessed on October 6, 2006.
15. Mattke S, Bergamo G, Balakrishnan A, Martino S, Vakkur N. Measuring and reporting the performance of disease management programs. RAND Health working paper no. WR-400. 2006.
16. SAS Institute Inc. SAS version 8.2. Cary, NC: SAS Institute Inc., 2002.
17. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care 2005;43:517-520.
18. Dezii CM. Persistence with drug therapy: a practical approach using administrative claims data. Manag Care 2001;10:42-45.
19. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-116.
20. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-1090.
21. Rudd P. The measurement of compliance: medication taking. In: Krasnegor NA, et al., eds. Developmental aspects of health compliance behavior. Hillsdale, NJ: Lawrence Erlbaum Associates, 1993.
22. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37:846-857.
23. DMAA (Disease Management Association of America). DMAA announces launch of project to develop standards for measuring, evaluating disease management outcomes. Available at: www.dmaa.org/news_ releases/2006/pressrelease_011706. html. Accessed October 10, 2006.